Markets:

Overview

News

Currencies

International

Treasuries

Insulet Corporation - Common Stock (NQ:PODD)

141.69 -4.32 (-2.96%)

Streaming Delayed Price Updated: 12:40 PM EDT, May 28, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Insulet Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

21 22 Next >

Peering Into Insulet Corp's Recent Short Interest ↗

November 20, 2025

Via Benzinga

Insulet Corp (NASDAQ:PODD) Presents a Compelling Affordable Growth Opportunity ↗

November 20, 2025

Insulet Corp (PODD) offers strong growth and profitability at a reasonable valuation. Its solid financial health makes it a top affordable growth stock.

Via Chartmill

$1000 Invested In Insulet 15 Years Ago Would Be Worth This Much Today ↗

November 19, 2025

Via Benzinga

3 Reasons We Love Insulet (PODD)

November 18, 2025

Since May 2025, Insulet has been in a holding pattern, posting a small return of 3% while floating around $335.74. The stock also fell short of the S&P 500’s 11.9% gain during that period.

Via StockStory

Topics Stocks

Insulet Corp (PODD) Shows Strong Technical and Fundamental Momentum ↗

November 18, 2025

Discover how Insulet Corp (PODD) combines strong technical uptrends with high-growth fundamentals, presenting a potential market leader for growth investors.

Via Chartmill

Earnings Scheduled For November 6, 2025 ↗

November 06, 2025

Via Benzinga

Price Over Earnings Overview: Insulet ↗

September 30, 2025

Via Benzinga

1 Healthcare Stock with Exciting Potential and 2 Facing Headwinds

November 11, 2025

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of...

Via StockStory

Topics Stocks

Insulet Corp (NASDAQ:PODD) Passes Stringent Growth Screen ↗

November 10, 2025

Discover how Insulet Corp exemplifies a powerful growth investing system, showcasing strong earnings, soaring sales, and impressive cash flow.

Via Chartmill

Gapping S&P500 stocks in Thursday's session ↗

November 06, 2025

Seeking insights into today's market movers? Discover the S&P500 gap up and gap down stocks in today's session on Thursday. Stay informed about the latest market trends.

Via Chartmill

Insulet Rises As Broad Omnipod Growth Stokes Beat-And-Raise Quarter ↗

November 06, 2025

Insulet stock rose moderately early Thursday as its insulin pump, Omnipod, delivered double-digit growth in the U.S. and abroad.

Via Investor's Business Daily

Stay updated with the S&P500 stocks that are on the move in today's pre-market session. ↗

November 06, 2025

Before the US market kicks off on Thursday, let's examine the pre-market session and unveil the notable performers among the S&P500 top gainers and losers.

Via Chartmill

Insulet’s (NASDAQ:PODD) Q3: Strong Sales

November 06, 2025

Insulin delivery company Insulet Corporation (NASDAQ:PODD) reported Q3 CY2025 results topping the market’s revenue expectations, with sales up 29.9% year on year to $706.3 million. On top of that, next...

Via StockStory

Insulet Reports Third Quarter 2025 Results

November 06, 2025

From Insulet Corporation

Via Business Wire

Examining the Future: Insulet's Earnings Outlook ↗

November 05, 2025

Via Benzinga

Insulet, Uber And A Financial Stock On CNBC's 'Final Trades' ↗

November 05, 2025

Joseph Terranova of Virtus Investment Partners named Insulet Corp., a maker of wearable devices for insulin management, as his final trade.

Via Benzinga

Earnings To Watch: Insulet (PODD) Reports Q3 Results Tomorrow

November 04, 2025

Insulin delivery company Insulet Corporation (NASDAQ:PODD) will be reporting results this Thursday before market hours. Here’s what investors should know.

Via StockStory

Peering Into Insulet Corp's Recent Short Interest ↗

October 31, 2025

Via Benzinga

$100 Invested In Insulet 15 Years Ago Would Be Worth This Much Today ↗

October 30, 2025

Via Benzinga

Insulet Champions Workplace Inclusion for People with Diabetes with New Data and Tools Released for Diabetes Awareness Month

October 30, 2025

From Insulet Corporation

Via Business Wire

INSULET CORP (NASDAQ:PODD) Demonstrates Strong Growth and Technical Momentum ↗

October 29, 2025

Discover Insulet (PODD), a top growth stock with strong financials and a positive technical setup, making it a compelling pick for investors.

Via Chartmill

1 Safe-and-Steady Stock to Own for Decades and 2 We Brush Off

October 27, 2025

Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets.

Via StockStory

INSULET CORP (NASDAQ:PODD): A Prime Candidate for Affordable Growth Investing ↗

October 25, 2025

Insulet (PODD) is a GARP stock with strong revenue & earnings growth, solid profitability, and a reasonable valuation relative to its industry peers.

Via Chartmill

Insulet Announces Appointment of Robert L. Huffines to its Board of Directors

October 23, 2025

From Insulet Corporation

Via Business Wire

Here's How Much You Would Have Made Owning Insulet Stock In The Last 10 Years ↗

October 21, 2025

Via Benzinga

Louis Navellier's Growth Strategy Highlights Insulet Corp (NASDAQ:PODD) ↗

October 20, 2025

Discover how Louis Navellier's growth stock strategy identified Insulet Corp (PODD), a leader in innovative insulin delivery with strong earnings and sales growth.

Via Chartmill

Insulet to Host Investor Day on November 20, 2025

October 10, 2025

From Insulet Corporation

Via Business Wire

Discover which S&P500 stocks are making waves on Thursday. ↗

October 09, 2025

Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Thursday.

Via Chartmill

What's going on in today's session: S&P500 gap up and gap down stocks ↗

October 01, 2025

Let's have a look at the S&P500 gap up and gap down stocks in today's session.

Via Chartmill

Here's How Much $100 Invested In Insulet 15 Years Ago Would Be Worth Today ↗

September 29, 2025

Insulet (NASDAQ: PODD) has outperformed the market over the past 15 years by 10.02% on an annualized basis producing an average annual return of 22.35%. Currently, Insulet has a market capitalization...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

21 22 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Insulet Corporation - Common Stock (NQ:PODD)

All News about Insulet Corporation - Common Stock

Resources